Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/24250
Title: A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Aged, 80 and over,Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use,Carboplatin/administration & dosage/adverse effects,Doxorubicin/administration & dosage/adverse effects/analogs & derivatives,Female,Humans,Kaplan-Meier Estimate,Middle Aged,Ovarian Neoplasms/diagnosis/*drug therapy,Paclitaxel/administration & dosage/adverse effects,Polyethylene Glycols/administration & dosage/adverse effects,Prognosis,Proportional Hazards Models,Treatment Outcome
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/24250
ISSN: 1741-7015
Link: http://www.ncbi.nlm.nih.gov/pubmed/20055981
http://www.biomedcentral.com/1741-7015/8/3
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Briasoulis-2010-a randomized phase.pdf332.03 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons